Intricate mechanism of anxiety disorder, recognizing the potential role of gut microbiota and therapeutic interventions
Authors:
- Sudarshan Singh LakhawatSudarshan Singh Lakhawat
- Priyanka MechPMPriyanka Mech
- Akhilesh KumarAKAkhilesh Kumar
- Naveen MalikNMNaveen Malik
- Vikram KumarVKVikram Kumar
- Vinay SharmaVSVinay Sharma
- Jasvinder Singh BhattiJBJasvinder Singh Bhatti
- Sunil JaswalSJSunil Jaswal
- Sunil KumarSKSunil Kumar
- Pushpender Kumar SharmaPSPushpender Kumar Sharma
- 13 December 2024
- journal article
- review article
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 40 (1) , 1-31
Abstract
Anxiety is a widespread psychological disorder affecting both humans and animals. It is a typical stress reaction; however, its longer persistence can cause severe health disorders affecting the day-to-day life activities of individuals. An intriguing facet of the anxiety-related disorder can be addressed better by investigating the role of neurotransmitters in regulating emotions, provoking anxiety, analyzing the cross-talks between neurotransmitters, and, most importantly, identifying the biomarkers of the anxiety. Recent years have witnessed the potential role of the gut microbiota in human health and disorders, including anxiety. Animal models are commonly used to study anxiety disorder as they offer a simpler and more controlled environment than humans. Ultimately, developing new strategies for diagnosing and treating anxiety is of paramount interest to medical scientists. Altogether, this review article shall highlight the intricate mechanisms of anxiety while emphasizing the emerging role of gut microbiota in regulating metabolic pathways through various interaction networks in the host. In addition, the review will foster information about the therapeutic interventions of the anxiety and related disorder. Graphical abstractKeywords
This publication has 255 references indexed in Scilit:
- Phenylacetylglutamine as a novel biomarker of type 2 diabetes with distal symmetric polyneuropathy by metabolomicsJournal of Endocrinological Investigation, 2022
- Design, synthesis, and computational studies of phenylacetamides as antidepressant agentsMolecular Diversity, 2022
- Mechanisms underlying remediation of depression-associated anxiety by chronic N-acetyl cysteine treatmentPsychopharmacology, 2020
- Using MetaboAnalyst 4.0 for Comprehensive and Integrative Metabolomics Data AnalysisCurrent Protocols in Bioinformatics, 2019
- Exposure‐induced changes of plasma metabolome and gene expression in patients with panic disorderDepression and Anxiety, 2019
- Comparison of selegiline and levodopa combination therapy versus levodopa monotherapy in the treatment of Parkinson’s disease: a meta-analysisAging Clinical and Experimental Research, 2019
- IDO and TDO as a potential therapeutic target in different types of depressionMetabolic Brain Disease, 2018
- Gabapentin and Pregabalin for the Treatment of Anxiety DisordersClinical Pharmacology in Drug Development, 2018
- Glutamate as a neurotransmitter in the healthy brainJournal of Neural Transmission, 2014
- Peripheral Administration of Loperamide and Methylnaloxone Decreases the Degree of Anxiety in RatsBulletin of Experimental Biology and Medicine, 2010